A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
Human egg cells are often prone to chromosomal errors. As women age, the error rate increases sharply - and can contribute to infertility, pregnancy ...
Human egg cells are often prone to chromosomal errors. As women age, the error rate increases sharply—and can contribute to ...
ProvenBase, an AI-powered talent intelligence platform, today announced the addition of globally recognized talent acquisition expert Shally Steckerl to its advisory board, concurrent with the company ...
Nov. 03, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical ... seeing with CB-011 combined with the off-the-shelf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback